Blenrep
Generic: belantamab mafodotin
- Manufacturer
- GlaxoSmithKline
- NDC
- 0173-0913
- RxCUI
- 2725585
- Route
- INTRAVENOUS
- ICD-10 indication
- C90.00
Affordability Check
How much will you actually pay for Blenrep?
In 30 seconds, see every legitimate way to afford Blenrep — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Blenrep
Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA); it was previously granted accelerated approval for adults with relapsed or refractory multiple myeloma who have received at least four prior therapies, but the US marketing authorization for this indication was withdrawn in November 2022.
Copay & patient assistance
- Patient Copay Amount: Not Publicly Available
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Eligible patients with commercial insurance; must be a US resident
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for belantamab mafodotin.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Blenrep →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for belantamab mafodotin →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Pomalyst
Treats same condition · pomalidomide
XTRENBO
Treats same condition · Denosumab-qbde
CARMUSTINE
Treats same condition · Carmustine
Pomalidomide
Treats same condition · Pomalidomide
Sarclisa
Treats same condition · isatuximab
NINLARO
Treats same condition · ixazomib
EVOMELA
Treats same condition · Melphalan
Mozobil
Treats same condition · PLERIXAFOR
Melphalan Hydrochloride
Treats same condition · Melphalan hydrochloride
Darzalex Faspro
Treats same condition · daratumumab and hyaluronidase-fihj (human recombinant)
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
Blenrep treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.